4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-23-001475
Chief Financial Officer gave up 1,470 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Holm-Jorgensen Rasmus · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-14 | Shares withheld for taxes : show line 1 in the form | −1,470 | $5.08 | $7,468 | 28,060 | D |
Loading xslF345X05/form4.xml…